Clinical Trial Update: A Study of TAK-360 in Adults With Idiopathic Hypersomnia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating TAK-360 in adults with idiopathic hypersomnia, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Hypersomnia

Drugs mentioned

• TAK-360

Snippet

Sponsor: Takeda | Conditions: Idiopathic Hypersomnia | Phase 2 | Status: RECRUITING